ATPC vs BYAH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a critically weak financial health with a Piotroski F-Score of 0/9, indicating severe operational and financial distress. Despite a low Price/Book ratio of 0.17 and a strong Current Ratio of 16.21, the company is deeply unprofitable with negative profit and operating margins exceeding -160%, and has lost 100% of its value over the past three to five years. Revenue growth of 11.9% YoY is overshadowed by deteriorating earnings and a lack of profitability, while the absence of key valuation metrics and analyst coverage further signals high risk. The stock's technical trend is deeply bearish, and insider sentiment is neutral at best, offering no catalyst for recovery.
BYAH shows bearish fundamentals based on deterministic rules. Financial strength is strong (F-Score 6/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
ATPC vs BYAH: Head-to-Head Comparison
This page compares Agape ATP Corporation (ATPC) and Park Ha Biological Technology Co., Ltd. (BYAH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.